Abstract
Syphilis is a systemic infectious disease known as the “Great Masquerader” for its ability to mimic a wide range of ocular conditions, potentially involving any ocular structure. We report the case of a 26-year-old man with a history of unprotected sexual intercourse who presented with a two-week history of a painful, red right eye without loss of visual acuity. Examination revealed nodular lesions on the temporal sclera and concomitant reddish-brown palmar spots. Laboratory tests were performed to determine the etiology of the anterior nodular scleritis. Serologic testing (treponema pallidum hemagglutination assay (TPHA)/Venereal Disease Research Laboratory test (VDRL)) was positive, confirming syphilitic nodular scleritis. The patient showed rapid clinical improvement following penicillin therapy.
Keywords: anterior nodular scleritis, cutaneous syphilis, ocular syphilis, penicillin g, syphilis
Introduction
Syphilis is a systemic infectious disease, often referred to as the “Great Masquerader” because of its ability to mimic a wide range of ocular conditions [1]. Ocular involvement can affect nearly any structure of the eye and most commonly presents as uveitis. In contrast, scleral involvement is rare, accounting for approximately 3% of ocular syphilis cases [2].
Within this spectrum, syphilitic anterior nodular scleritis is a rare presentation. Its clinical features often overlap with those of other inflammatory scleral diseases, which can make the diagnosis challenging and lead to delays in appropriate management. Awareness of this rare entity is essential to ensure prompt recognition and appropriate management. Notably, syphilitic scleritis typically shows a poor response to corticosteroid therapy, whereas it demonstrates a favorable response to penicillin treatment [3].
Case presentation
We report the case of a 26-year-old male prisoner who presented to the ophthalmology emergency department with a painful, red right eye for two weeks without a decrease in visual acuity. The patient reported having no particular medical history or general symptoms apart from a non-itchy rash on the palms of his hands. Furthermore, the patient reported a history of unprotected sexual intercourse.
The clinical examination found a visual acuity of 20/20 in both eyes. Slit-lamp examination found two solid, injected, nonmobile nodular lesions measuring 4 mm each located on the temporal sclera of the right eye (Figure 1).
Figure 1. Right eye showing anterior nodular scleritis.
The rest of the examination of both eyes was strictly normal. The intraocular pressure was 10 mmHg for the right eye and 12 mmHg for the left eye, with a deep and quiet anterior chamber and a normal fundoscopic examination in both eyes. On the palms of the patient’s hands, reddish-brown spots were observed (Figure 2).
Figure 2. Hand of the patient showing palmar lesions.
Laboratory tests were performed to determine the etiology of the nodular scleritis. These tests included complete blood count, angiotensin-converting enzyme, QuantiFERON test for tuberculosis, Treponema pallidum antibodies, and rheumatoid factor. A chest radiograph was also performed. All the results came back negative except for the treponema pallidum hemagglutination assay (TPHA)/Venereal Disease Research Laboratory test (VDRL), which came back positive. The patient was then referred to a neurologist for a neurological examination and a lumbar puncture, the result of which was normal (Table 1).
Table 1. Findings of the laboratory investigations of the patient.
CSF, cerebrospinal fluid; TPHA, treponema pallidum hemagglutination assay; VDRL, Venereal Disease Research Laboratory test
| Parameters | Patient values | Reference range |
| Hemoglobin | 14 g/dL | 13-17 g/dL |
| White blood cell count | 5500 cells per microliter | 4000-11000 cells per microliter |
| Platelet count | 250000 platelets per microliter | 150000-450000 platelets per microliter |
| Angiotensin-converting enzyme | 25 U/L | 20-70 U/L |
| QuantiFERON | 0.1 U/mL | ≤0.35 U/mL |
| TPHA | Positive | Negative |
| VDRL | 1:64 (positive) | Negative |
| Rheumatoid factor | 5 U/mL | <20 U/mL |
| Appearance of the CSF | Clear | Clear |
| Opening pressure | 14 cmH₂O | 10-20 cmH₂O |
| White blood cells (CSF) | 2 cells/mm³ | 0-5 cells/mm³ |
| Glucose (CSF) | 2.8 mmol/L | 2.5-4.5 mmol/L |
| Protein (CSF) | 0.35 g/L | 0.15-0.45 g/L |
Aqueous crystalline penicillin G was administered intravenously to the patient at a dose of 18-24 million units per day for 14 days. The clinical course was marked by a rapid improvement of the lesions within 10 days (Figure 3). In addition, serological testing for human immunodeficiency virus (HIV) and hepatitis B and C was performed and returned negative results.
Figure 3. Right eye showing the evolution of the scleritis after treatment.
Discussion
Syphilis is a systemic infectious disease caused by the spirochete Treponema pallidum, primarily transmitted through sexual contact with infectious lesions [1]. Owing to its hematogenous dissemination, the disease can involve multiple ocular structures, including the conjunctiva, cornea, sclera, and optic nerve. Consequently, ocular syphilis presents with a wide spectrum of manifestations, such as interstitial keratitis, uveitis, and papillitis [3].
Among these manifestations, syphilitic scleritis remains a rare entity, accounting for approximately 3% of ocular syphilis cases. It most frequently presents as anterior nodular scleritis [2,4]. The rarity of this condition, combined with its nonspecific clinical presentation, contributes to diagnostic challenges.
Syphilis is often referred to as “the great imitator” due to its ability to mimic a variety of other diseases. In the context of anterior nodular scleritis, several differential diagnoses must be considered, including infectious and autoimmune conditions such as tuberculosis, giant cell arteritis, sarcoidosis, and rheumatoid arthritis [5]. This overlap in clinical features underscores the importance of thorough etiological investigation.
From a therapeutic perspective, syphilitic scleritis typically demonstrates a poor or limited response to corticosteroid therapy when used alone. In contrast, it responds favorably to appropriate antibiotic treatment. The standard regimen for ocular syphilis consists of aqueous crystalline penicillin G administered intravenously at a dose of 18-24 million units per day for 10 to 14 days. Alternatively, intramuscular procaine penicillin (2.4 million units daily) may be used over the same duration [6].
Consistent with the literature, previously reported cases of syphilitic nodular scleritis have shown favorable outcomes following antibiotic therapy, with resolution of scleral nodules generally observed within one to two weeks after initiation of treatment [2,4]. This rapid clinical improvement further supports the infectious etiology and highlights the importance of early diagnosis and targeted management.
Conclusions
Even though syphilitic scleritis is rare, it should be suspected and ruled out in all patients with scleritis for rapid diagnosis and treatment, especially since syphilitic scleritis responds very well to penicillin therapy.
Furthermore, it is important to educate the general public about the prevention of syphilis and other sexually transmitted diseases as part of the primary prevention of these diseases and to promote the use of condoms.
Disclosures
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.
Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.
Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Author Contributions
Concept and design: Meryem Benchekroun, Saad Benchekroun, Narjisse Taouri, Lalla Ouafa Cherkaoui
Acquisition, analysis, or interpretation of data: Meryem Benchekroun, Saad Benchekroun, Narjisse Taouri, Lalla Ouafa Cherkaoui
Drafting of the manuscript: Meryem Benchekroun, Saad Benchekroun, Narjisse Taouri
Critical review of the manuscript for important intellectual content: Meryem Benchekroun, Saad Benchekroun, Narjisse Taouri, Lalla Ouafa Cherkaoui
Supervision: Meryem Benchekroun, Saad Benchekroun, Narjisse Taouri, Lalla Ouafa Cherkaoui
References
- 1.Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Singh AE, Romanowski B. Clin Microbiol Rev. 1999;12:187–209. doi: 10.1128/cmr.12.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Syphilitic episcleritis and scleritis. Wilhelmus KR, Yokoyama CM. Am J Ophthalmol. 1987;104:595–597. doi: 10.1016/0002-9394(87)90170-x. [DOI] [PubMed] [Google Scholar]
- 3.Nodular syphilitic scleritis masquerading as an ocular tumor. Shaikh SI, Biswas J, Rishi P. J Ophthalmic Inflamm Infect. 2015;5:8. doi: 10.1186/s12348-015-0040-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Anterior nodular scleritis secondary to syphilis. Casey R, Flowers CW Jr, Jones DD, Scott L. Arch Ophthalmol. 1996;114:1015–1016. doi: 10.1001/archopht.1996.01100140223022. [DOI] [PubMed] [Google Scholar]
- 5.Unilateral nodular scleritis secondary to latent syphilis. Escott SM, Pyatetsky D. Clin Med Res. 2015;13:94–95. doi: 10.3121/cmr.2015.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nodular syphilitic scleritis: a rare and forgotten entity. Kanathur S, Hongal AA, Radhika SR, Revathi TN. Int J STD AIDS. 2021;32:766–767. doi: 10.1177/0956462420986665. [DOI] [PubMed] [Google Scholar]



